A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma.
Sullivan RJ, Ibrahim N, Lawrence DP, Aldridge J, Giobbie-Hurder A, Hodi FS, Flaherty KT, Conley C, Mier JW, Atkins MB, McDermott DF.
Sullivan RJ, et al.
Oncologist. 2015 Jun;20(6):617-8. doi: 10.1634/theoncologist.2015-0105. Epub 2015 May 18.
Oncologist. 2015.
PMID: 25986244
Free PMC article.
Clinical Trial.